Skip to content

Identification of changes in nutritional status and psychosomatic function during supplement use.

Research on psychosomatic function with nutritional supplements. -placebo-controlled crossover trial- - Research on psychosomatic function with nutritional supplements.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000055952
Enrollment
35
Registered
2024-10-25
Start date
2024-10-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects

Interventions

Placebo food intake (14 days) --&gt
Washout period (4 weeks or more) --&gt
Test food intake (14 days) Test food intake (14 days) --&gt
Placebo food intake (14 days)

Sponsors

Toyo University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. healthy men and women aged between 18 and 39 years at the time of consent 2. Persons who have been fully informed of the purpose and content of the research, have the capacity to consent, understand it well, volunteer to participate in the study, and give their written consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. those taking daily dietary supplements or medicines and who are unable to discontinue them during the study. 2. smokers or those who have not quit smoking for at least 3 months 3. have a current or previous history of allergy to any of the ingredients of the food being studied 4. who are pregnant or breastfeeding, or who may become pregnant or plan to become pregnant or breastfeed during the study period. 5. persons suffering from gastrointestinal disorders resulting in malabsorption, such as dyspepsia syndrome or gastrectomy 6. who are currently participating in another clinical trial or who have participated in another clinical trial or clinical study within the last month prior to the date of consent, 7. who are currently participating in another clinical trial, or who have participated in another clinical trial or study within the last month prior to the date of consent, or who intend to participate during this trial; or currently receiving regular hospital treatment for any medical condition 8. any other person who, in the opinion of the investigator or physician, is unsuitable as a subject for this trial.

Design outcomes

Primary

MeasureTime frame
-Comparison of serum brain-derived neurotrophic factor concentrations -Comparison of changes in anxiety scale and competitive psychology

Secondary

MeasureTime frame
-Comparison of attention and concentration measurements -Comparison of changes in blood vitamins, various intermediary metabolites, antioxidant effects, etc.

Countries

Japan

Contacts

Public ContactNaho Serizawa

Toyo University Faculty of Health and Sports Sciences

serizawa@toyo.jp03-5924-2819

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026